Don't use this pen if the liquid appears to be coloured, cloudy, thickened or contains particles
The most frequently reported ones include nausea, flushing (a feeling of warmth or redness in the face and neck), and mild headaches
If this can be better understood I hope for the emergence of new therapeutics
RTDs, mocktails and functional formats are gaining traction, especially among Gen-Z and millennials
It was FDA-approved in 1997 under the brand name Geref for growth hormone deficiency in children, administered exclusively as a subcutaneous injection
Published Phase 3 weight-loss results for retatrutide exceed those reported for tirzepatide (22.5% in SURMOUNT-1) and semaglutide (14.9% in STEP-1) at comparable timepoints [1][2][9]